MD Anderson And BridgeBio Pharma Launch Navire Pharma To Develop Targeted Therapy For Patients With Difficult-to-treat Cancer

Wednesday, October 4, 2017 1 min read

Key Takeaway: MD Anderson And BridgeBio Pharma Launch Navire Pharma To Develop Targeted Therapy For Patients With Difficult-to-treat Cancer

Full Press Release Details

MD Anderson And BridgeBio Pharma Launch Navire Pharma To Develop Targeted Therapy For Patients With Difficult-to-treat Cancer.